Tandem Diabetes Care (TNDM) Institutional Ownership

Of the 269 institutional investors that purchased Tandem Diabetes Care's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sessa Capital IM L.P. ($4.47M), Freestone Grove Partners LP ($2.05M), First Light Asset Management LLC ($1.55M), Hood River Capital Management LLC ($1.53M), Ophir Asset Management Pty Ltd ($1.46M), Assenagon Asset Management S.A. ($1.41M), and ArrowMark Colorado Holdings LLC ($1.33M).

Institutional investors have bought a total of 18,938,704 shares in the last 24 months. This purchase volume represents approximately $344.34M in transactions.

Of the 97 institutional investors that sold Tandem Diabetes Care's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BNP Paribas Financial Markets ($9.80M), JPMorgan Chase & Co. ($1.41M), Invesco Ltd. ($1.28M), Assenagon Asset Management S.A. ($1.05M), Universal Beteiligungs und Servicegesellschaft mbH ($998.73K), ArrowMark Colorado Holdings LLC ($801.51K), and Balyasny Asset Management L.P. ($538.81K).

Institutional investors have sold a total of 22,712,679 shares in the last 24 months. This volume of shares sold represents approximately $354.73M in transactions.